Bosh sahifaPHIO • NASDAQ
add
Phio Pharmaceuticals Corp
2,70 $
Seans yopilganidan keyin:(0,00%)0,00
2,70 $
Yopilgan:16-apr, 16:05:31 (GMT-4) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
2,43 $
Kunlik diapazon
2,35 $ - 2,94 $
Yillik diapazon
0,97 $ - 9,79 $
Bozor kapitalizatsiyasi
12,90 mln USD
Oʻrtacha hajm
5,65 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 689,00 ming | -10,05% |
Sof foyda | -1,63 mln | 14,20% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | — | — |
EBITDA | -1,67 mln | 5,05% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 5,38 mln | -36,61% |
Jami aktivlari | 5,74 mln | -38,72% |
Jami passivlari | 1,02 mln | -37,88% |
Umumiy kapital | 4,72 mln | — |
Tarqatilgan aksiyalar | 4,78 mln | — |
Narxi/balansdagi bahosi | 0,89 | — |
Aktivlardan daromad | -72,14% | — |
Kapitaldan daromad | -86,57% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,63 mln | 14,20% |
Operatsiyalardan naqd pul | -1,37 mln | 42,15% |
Sarmoyadan naqd pul | 8,00 ming | — |
Moliyadan naqd pul | 1,36 mln | -43,61% |
Naqd pulning sof oʻzgarishi | -8,00 ming | -124,24% |
Boʻsh pul | -783,25 ming | 51,92% |
Haqida
Phio Pharmaceuticals Corporation is a US clinical stage biotechnology company developing its INTASYL siRNA in immuno-oncology. Formerly known as RXi Pharmaceuticals, the company's name was changed to Phio Pharmaceuticals in 2018. Wikipedia
Tashkil etilgan
2011
Sayt
Xodimlar soni
5
